

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 9.99224596 |
| 2 | DNA deamination (GO:0045006) | 8.82462074 |
| 3 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 8.55569654 |
| 4 | cellular response to interleukin-15 (GO:0071350) | 8.42345364 |
| 5 | * cytolysis (GO:0019835) | 8.05389713 |
| 6 | response to interleukin-15 (GO:0070672) | 7.36701828 |
| 7 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 7.35877182 |
| 8 | regulation of natural killer cell mediated immunity (GO:0002715) | 7.35877182 |
| 9 | activated T cell proliferation (GO:0050798) | 6.82414865 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.30436039 |
| 11 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 6.24825024 |
| 12 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 6.24825024 |
| 13 | negative regulation by host of viral transcription (GO:0043922) | 6.01414364 |
| 14 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.79632907 |
| 15 | positive regulation of isotype switching (GO:0045830) | 5.78455837 |
| 16 | cellular defense response (GO:0006968) | 5.60508728 |
| 17 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 5.41084342 |
| 18 | negative regulation of cell killing (GO:0031342) | 5.32464139 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.32464139 |
| 20 | positive regulation of B cell mediated immunity (GO:0002714) | 5.26236651 |
| 21 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 5.26236651 |
| 22 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 5.23704750 |
| 23 | regulation of cell killing (GO:0031341) | 5.14181556 |
| 24 | T cell migration (GO:0072678) | 5.08854453 |
| 25 | positive regulation of lymphocyte migration (GO:2000403) | 5.08315707 |
| 26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.03759770 |
| 27 | negative T cell selection (GO:0043383) | 5.02458101 |
| 28 | positive thymic T cell selection (GO:0045059) | 4.95155799 |
| 29 | positive regulation of cell killing (GO:0031343) | 4.92407751 |
| 30 | negative thymic T cell selection (GO:0045060) | 4.88661419 |
| 31 | positive regulation of DNA recombination (GO:0045911) | 4.88232130 |
| 32 | lymphocyte chemotaxis (GO:0048247) | 4.83557397 |
| 33 | regulation of response to tumor cell (GO:0002834) | 4.71338802 |
| 34 | positive regulation of response to tumor cell (GO:0002836) | 4.71338802 |
| 35 | positive regulation of immune response to tumor cell (GO:0002839) | 4.71338802 |
| 36 | regulation of immune response to tumor cell (GO:0002837) | 4.71338802 |
| 37 | eosinophil chemotaxis (GO:0048245) | 4.69391112 |
| 38 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.68822291 |
| 39 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.67260477 |
| 40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.67260477 |
| 41 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.56684157 |
| 42 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.42177920 |
| 43 | negative regulation of viral genome replication (GO:0045071) | 4.40978401 |
| 44 | tyrosine phosphorylation of STAT protein (GO:0007260) | 4.39455154 |
| 45 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.36828551 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 4.35599359 |
| 47 | natural killer cell activation (GO:0030101) | 4.35266912 |
| 48 | response to protozoan (GO:0001562) | 4.26848551 |
| 49 | leukocyte aggregation (GO:0070486) | 4.26735542 |
| 50 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.26610336 |
| 51 | regulation of isotype switching (GO:0045191) | 4.23787074 |
| 52 | positive T cell selection (GO:0043368) | 4.23190924 |
| 53 | regulation of regulatory T cell differentiation (GO:0045589) | 4.22503485 |
| 54 | eosinophil migration (GO:0072677) | 4.22098501 |
| 55 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 4.21826417 |
| 56 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.19791749 |
| 57 | regulation of chronic inflammatory response (GO:0002676) | 4.19558745 |
| 58 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.17823764 |
| 59 | regulation of immunoglobulin mediated immune response (GO:0002889) | 4.14720599 |
| 60 | defense response to protozoan (GO:0042832) | 4.11289367 |
| 61 | thymic T cell selection (GO:0045061) | 4.08400126 |
| 62 | regulation of B cell mediated immunity (GO:0002712) | 4.04418839 |
| 63 | positive regulation of immunoglobulin production (GO:0002639) | 4.00491795 |
| 64 | mast cell activation (GO:0045576) | 3.96008429 |
| 65 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.91488917 |
| 66 | regulation of lymphocyte migration (GO:2000401) | 3.82022354 |
| 67 | regulation of RIG-I signaling pathway (GO:0039535) | 3.81244009 |
| 68 | regulation of response to interferon-gamma (GO:0060330) | 3.79676124 |
| 69 | negative regulation of viral transcription (GO:0032897) | 3.79529112 |
| 70 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.75497036 |
| 71 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.75059177 |
| 72 | modulation by host of symbiont transcription (GO:0052472) | 3.75040980 |
| 73 | modulation by host of viral transcription (GO:0043921) | 3.75040980 |
| 74 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.73154981 |
| 75 | T cell proliferation (GO:0042098) | 3.69990231 |
| 76 | macrophage chemotaxis (GO:0048246) | 3.69045208 |
| 77 | negative regulation of T cell apoptotic process (GO:0070233) | 3.69021121 |
| 78 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.68376736 |
| 79 | regulation of B cell differentiation (GO:0045577) | 3.68194979 |
| 80 | positive regulation of T cell cytokine production (GO:0002726) | 3.66332155 |
| 81 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.60849670 |
| 82 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.60849670 |
| 83 | T cell differentiation involved in immune response (GO:0002292) | 3.60849670 |
| 84 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.60220001 |
| 85 | lymphocyte migration (GO:0072676) | 3.59486389 |
| 86 | regulation of memory T cell differentiation (GO:0043380) | 3.58617212 |
| 87 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.57908783 |
| 88 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.57284107 |
| 89 | positive regulation of humoral immune response (GO:0002922) | 3.54038987 |
| 90 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 3.53078158 |
| 91 | positive regulation of macrophage differentiation (GO:0045651) | 3.52157403 |
| 92 | myeloid dendritic cell differentiation (GO:0043011) | 3.50956146 |
| 93 | myeloid dendritic cell activation (GO:0001773) | 3.49384664 |
| 94 | positive regulation of T cell migration (GO:2000406) | 3.49195255 |
| 95 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.48741538 |
| 96 | T cell receptor signaling pathway (GO:0050852) | 3.47556744 |
| 97 | T cell costimulation (GO:0031295) | 3.46105443 |
| 98 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.43643142 |
| 99 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.42838670 |
| 100 | negative regulation of interleukin-12 production (GO:0032695) | 3.41442993 |
| 101 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 3.41242220 |
| 102 | T cell selection (GO:0045058) | 3.40761939 |
| 103 | thrombin receptor signaling pathway (GO:0070493) | 3.40052323 |
| 104 | lymphocyte costimulation (GO:0031294) | 3.39582629 |
| 105 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.39024417 |
| 106 | DNA demethylation (GO:0080111) | 3.34967875 |
| 107 | positive regulation of interferon-gamma production (GO:0032729) | 3.34682290 |
| 108 | NIK/NF-kappaB signaling (GO:0038061) | 3.34124674 |
| 109 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.32627285 |
| 110 | negative regulation of viral process (GO:0048525) | 3.30872491 |
| 111 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.30539455 |
| 112 | negative regulation of interleukin-2 production (GO:0032703) | 3.29186872 |
| 113 | negative regulation of T cell mediated immunity (GO:0002710) | 3.27701553 |
| 114 | T cell homeostasis (GO:0043029) | 3.27308747 |
| 115 | regulation of immunoglobulin production (GO:0002637) | 3.26272447 |
| 116 | regulation of viral genome replication (GO:0045069) | 3.22991216 |
| 117 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.22290778 |
| 118 | regulation of T cell chemotaxis (GO:0010819) | 3.21707487 |
| 119 | positive regulation of T cell chemotaxis (GO:0010820) | 3.21707487 |
| 120 | negative regulation of phagocytosis (GO:0050765) | 3.20326662 |
| 121 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.20316750 |
| 122 | regulation of leukocyte mediated immunity (GO:0002703) | 3.20254792 |
| 123 | regulation of T-helper 1 type immune response (GO:0002825) | 3.19485253 |
| 124 | positive regulation of B cell differentiation (GO:0045579) | 3.14744273 |
| 125 | alpha-beta T cell activation (GO:0046631) | 3.11561029 |
| 126 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.11251047 |
| 127 | regulation of T cell tolerance induction (GO:0002664) | 3.09796339 |
| 128 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 3.06903611 |
| 129 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.06868285 |
| 130 | alpha-beta T cell differentiation (GO:0046632) | 3.06466238 |
| 131 | regulation of T cell migration (GO:2000404) | 3.06086257 |
| 132 | positive regulation of defense response to virus by host (GO:0002230) | 3.06000671 |
| 133 | positive regulation of tolerance induction (GO:0002645) | 3.04923696 |
| 134 | regulation of calcium-mediated signaling (GO:0050848) | 3.02308353 |
| 135 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.02139145 |
| 136 | mast cell activation involved in immune response (GO:0002279) | 3.01447916 |
| 137 | mast cell degranulation (GO:0043303) | 3.01447916 |
| 138 | dendritic cell chemotaxis (GO:0002407) | 3.00466966 |
| 139 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.00249997 |
| 140 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.99874708 |
| 141 | citrulline biosynthetic process (GO:0019240) | 2.99717626 |
| 142 | regulation of hypersensitivity (GO:0002883) | 2.99076743 |
| 143 | negative regulation of B cell proliferation (GO:0030889) | 2.95805842 |
| 144 | regulation of interleukin-8 secretion (GO:2000482) | 2.95541410 |
| 145 | lymph node development (GO:0048535) | 2.94678752 |
| 146 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.94280811 |
| 147 | negative regulation of T cell activation (GO:0050868) | 2.91302041 |
| 148 | interferon-gamma production (GO:0032609) | 11.6733706 |
| 149 | cytidine deamination (GO:0009972) | 10.9420200 |
| 150 | cytidine metabolic process (GO:0046087) | 10.9420200 |
| 151 | cytidine catabolic process (GO:0006216) | 10.9420200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.41854875 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.72182994 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.55479475 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.68486858 |
| 5 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.38608507 |
| 6 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.31966954 |
| 7 | MYB_26560356_Chip-Seq_TH2_Human | 3.40020177 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.31082454 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.28680361 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.14697083 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.14632335 |
| 12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.12642383 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.12254570 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.91103015 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.87944852 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.86340514 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 2.78503268 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.72554995 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.65326035 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.53345861 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.44429278 |
| 22 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.44323676 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.44230555 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.30113181 |
| 25 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.28765735 |
| 26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.24222444 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.16855759 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.15520195 |
| 29 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.14191370 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.14185402 |
| 31 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.12859995 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.00994396 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.00733332 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.91152273 |
| 35 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.84616135 |
| 36 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.82293165 |
| 37 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.82024749 |
| 38 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.78534634 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.77467433 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.75102580 |
| 41 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.73746666 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.73454634 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72048352 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.71311267 |
| 45 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.70060439 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68606691 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64312019 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.60793471 |
| 49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58763902 |
| 50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57482792 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54647038 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53947881 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53465496 |
| 54 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53254885 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51929886 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50025994 |
| 57 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.41979213 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39378495 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.39153322 |
| 60 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36676751 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.34730797 |
| 62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30781137 |
| 63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27564415 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.27377327 |
| 65 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.25673301 |
| 66 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.23956682 |
| 67 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20630959 |
| 68 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.20225185 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15618334 |
| 70 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.15335719 |
| 71 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14536023 |
| 72 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09322702 |
| 73 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.08202221 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07055705 |
| 75 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05577794 |
| 76 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.01288840 |
| 77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00705526 |
| 78 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99966496 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.99291765 |
| 80 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.97836919 |
| 81 | VDR_22108803_ChIP-Seq_LS180_Human | 0.97796828 |
| 82 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.96739638 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96035249 |
| 84 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.95641350 |
| 85 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.95402593 |
| 86 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.95315106 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.93929306 |
| 88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93809015 |
| 89 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.93595800 |
| 90 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92714114 |
| 91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92337291 |
| 92 | GATA3_26560356_Chip-Seq_TH1_Human | 0.90955110 |
| 93 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.90095816 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88222743 |
| 95 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87295656 |
| 96 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87277523 |
| 97 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.87174403 |
| 98 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86512192 |
| 99 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.86317683 |
| 100 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.85553738 |
| 101 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85202435 |
| 102 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84648790 |
| 103 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84626023 |
| 104 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.82793299 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82294341 |
| 106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82113174 |
| 107 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81785721 |
| 108 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.81270737 |
| 109 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.81257110 |
| 110 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.81066718 |
| 111 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80615354 |
| 112 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.80038713 |
| 113 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.79926456 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79900266 |
| 115 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.79582395 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77753719 |
| 117 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.77440797 |
| 118 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.76967837 |
| 119 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.76316142 |
| 120 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.76204312 |
| 121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75556965 |
| 122 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.74931461 |
| 123 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74758423 |
| 124 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.74695959 |
| 125 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 0.74498722 |
| 126 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74470249 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.72982616 |
| 128 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.72014365 |
| 129 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.71837719 |
| 130 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71256516 |
| 131 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.71053398 |
| 132 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.70174888 |
| 133 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.70174888 |
| 134 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70104730 |
| 135 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69976861 |
| 136 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.69167585 |
| 137 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.69127131 |
| 138 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.69061504 |
| 139 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68894789 |
| 140 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.68868163 |
| 141 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.68536424 |
| 142 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.68182626 |
| 143 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.67618943 |
| 144 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67396543 |
| 145 | GATA1_22025678_ChIP-Seq_K562_Human | 0.66254187 |
| 146 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.65396180 |
| 147 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.65134810 |
| 148 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.65112708 |
| 149 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.64615959 |
| 150 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.64262654 |
| 151 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.63488540 |
| 152 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.62832644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 8.42079248 |
| 2 | MP0006082_CNS_inflammation | 6.51600190 |
| 3 | MP0010307_abnormal_tumor_latency | 3.65201382 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.33649922 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.24522649 |
| 6 | MP0009333_abnormal_splenocyte_physiolog | 3.03562618 |
| 7 | MP0001800_abnormal_humoral_immune | 3.00961860 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.96354095 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.86794473 |
| 10 | MP0009785_altered_susceptibility_to | 2.77033428 |
| 11 | MP0005025_abnormal_response_to | 2.70488625 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.64770408 |
| 13 | MP0002723_abnormal_immune_serum | 2.58783790 |
| 14 | * MP0002420_abnormal_adaptive_immunity | 2.57596732 |
| 15 | * MP0003448_altered_tumor_morphology | 2.54220447 |
| 16 | * MP0001819_abnormal_immune_cell | 2.52400084 |
| 17 | MP0002398_abnormal_bone_marrow | 2.41681121 |
| 18 | MP0001873_stomach_inflammation | 2.31927322 |
| 19 | MP0003950_abnormal_plasma_membrane | 2.24837804 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.17407060 |
| 21 | MP0000703_abnormal_thymus_morphology | 2.09076326 |
| 22 | * MP0000716_abnormal_immune_system | 2.05973072 |
| 23 | MP0002405_respiratory_system_inflammati | 2.03544924 |
| 24 | MP0002722_abnormal_immune_system | 2.03423329 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.98197609 |
| 26 | MP0000858_altered_metastatic_potential | 1.96039882 |
| 27 | MP0000689_abnormal_spleen_morphology | 1.88266427 |
| 28 | * MP0005387_immune_system_phenotype | 1.85908273 |
| 29 | * MP0001790_abnormal_immune_system | 1.85908273 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.77622118 |
| 31 | MP0003866_abnormal_defecation | 1.77193631 |
| 32 | * MP0002429_abnormal_blood_cell | 1.70467944 |
| 33 | MP0002006_tumorigenesis | 1.70124850 |
| 34 | MP0003436_decreased_susceptibility_to | 1.67048812 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.64206492 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.61934799 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.57622097 |
| 38 | MP0002148_abnormal_hypersensitivity_rea | 1.56919724 |
| 39 | MP0004947_skin_inflammation | 1.54951280 |
| 40 | MP0000372_irregular_coat_pigmentation | 1.53803002 |
| 41 | MP0002419_abnormal_innate_immunity | 1.51446702 |
| 42 | MP0000685_abnormal_immune_system | 1.51323466 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.50718664 |
| 44 | MP0001851_eye_inflammation | 1.49758165 |
| 45 | MP0004510_myositis | 1.45950957 |
| 46 | MP0002163_abnormal_gland_morphology | 1.42467752 |
| 47 | MP0000490_abnormal_crypts_of | 1.42143949 |
| 48 | MP0008469_abnormal_protein_level | 1.41026122 |
| 49 | MP0003724_increased_susceptibility_to | 1.39735605 |
| 50 | MP0001958_emphysema | 1.39507119 |
| 51 | MP0008057_abnormal_DNA_replication | 1.39096715 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.32603744 |
| 53 | MP0005360_urolithiasis | 1.30815432 |
| 54 | MP0002132_abnormal_respiratory_system | 1.26489269 |
| 55 | MP0003303_peritoneal_inflammation | 1.20628168 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.19656096 |
| 57 | MP0002019_abnormal_tumor_incidence | 1.19319643 |
| 58 | MP0003693_abnormal_embryo_hatching | 1.17390738 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.16993861 |
| 60 | MP0001501_abnormal_sleep_pattern | 1.15486066 |
| 61 | MP0005166_decreased_susceptibility_to | 1.12657865 |
| 62 | MP0000343_altered_response_to | 1.11478991 |
| 63 | * MP0009763_increased_sensitivity_to | 1.11385267 |
| 64 | MP0005174_abnormal_tail_pigmentation | 1.10445999 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.07482255 |
| 66 | MP0005310_abnormal_salivary_gland | 1.05216104 |
| 67 | MP0000920_abnormal_myelination | 1.05199069 |
| 68 | MP0001502_abnormal_circadian_rhythm | 1.04279234 |
| 69 | MP0004145_abnormal_muscle_electrophysio | 0.99946978 |
| 70 | MP0000015_abnormal_ear_pigmentation | 0.99759762 |
| 71 | MP0000604_amyloidosis | 0.93834426 |
| 72 | MP0001853_heart_inflammation | 0.93508540 |
| 73 | MP0001533_abnormal_skeleton_physiology | 0.91600941 |
| 74 | MP0002095_abnormal_skin_pigmentation | 0.90645918 |
| 75 | MP0003172_abnormal_lysosome_physiology | 0.88381122 |
| 76 | MP0008873_increased_physiological_sensi | 0.88183402 |
| 77 | MP0001919_abnormal_reproductive_system | 0.88150121 |
| 78 | MP0003786_premature_aging | 0.88003249 |
| 79 | MP0002998_abnormal_bone_remodeling | 0.87628272 |
| 80 | MP0004957_abnormal_blastocyst_morpholog | 0.84577716 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 0.84136141 |
| 82 | MP0005319_abnormal_enzyme/_coenzyme | 0.83413459 |
| 83 | MP0001545_abnormal_hematopoietic_system | 0.80345856 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 0.80345856 |
| 85 | MP0005379_endocrine/exocrine_gland_phen | 0.79512074 |
| 86 | MP0002933_joint_inflammation | 0.79507169 |
| 87 | MP0010234_abnormal_vibrissa_follicle | 0.78427946 |
| 88 | MP0010352_gastrointestinal_tract_polyps | 0.76817229 |
| 89 | MP0002876_abnormal_thyroid_physiology | 0.74094546 |
| 90 | MP0003329_amyloid_beta_deposits | 0.73903669 |
| 91 | MP0002254_reproductive_system_inflammat | 0.73679711 |
| 92 | MP0003878_abnormal_ear_physiology | 0.73670271 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 0.73670271 |
| 94 | MP0003566_abnormal_cell_adhesion | 0.70097560 |
| 95 | MP0005165_increased_susceptibility_to | 0.69984028 |
| 96 | MP0000609_abnormal_liver_physiology | 0.67850916 |
| 97 | MP0004742_abnormal_vestibular_system | 0.65806742 |
| 98 | MP0000627_abnormal_mammary_gland | 0.64744911 |
| 99 | MP0005410_abnormal_fertilization | 0.64561556 |
| 100 | MP0003943_abnormal_hepatobiliary_system | 0.64048699 |
| 101 | MP0001765_abnormal_ion_homeostasis | 0.62910092 |
| 102 | MP0001905_abnormal_dopamine_level | 0.61942181 |
| 103 | MP0002693_abnormal_pancreas_physiology | 0.60808732 |
| 104 | MP0001663_abnormal_digestive_system | 0.60375077 |
| 105 | MP0002168_other_aberrant_phenotype | 0.57669538 |
| 106 | MP0003567_abnormal_fetal_cardiomyocyte | 0.57296491 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.56197753 |
| 108 | MP0000613_abnormal_salivary_gland | 0.55239726 |
| 109 | MP0001542_abnormal_bone_strength | 0.55204959 |
| 110 | MP0005076_abnormal_cell_differentiation | 0.54062743 |
| 111 | MP0006036_abnormal_mitochondrial_physio | 0.54054968 |
| 112 | MP0008770_decreased_survivor_rate | 0.53724302 |
| 113 | MP0010094_abnormal_chromosome_stability | 0.53170218 |
| 114 | MP0003075_altered_response_to | 0.52702038 |
| 115 | MP0001727_abnormal_embryo_implantation | 0.52581961 |
| 116 | MP0002086_abnormal_extraembryonic_tissu | 0.52008898 |
| 117 | MP0005636_abnormal_mineral_homeostasis | 0.51447180 |
| 118 | MP0000371_diluted_coat_color | 0.51214000 |
| 119 | MP0009764_decreased_sensitivity_to | 0.50193723 |
| 120 | MP0005645_abnormal_hypothalamus_physiol | 0.48816290 |
| 121 | MP0003045_fibrosis | 0.48345653 |
| 122 | MP0000477_abnormal_intestine_morphology | 0.47719211 |
| 123 | MP0005075_abnormal_melanosome_morpholog | 0.46901971 |
| 124 | MP0000249_abnormal_blood_vessel | 0.45369400 |
| 125 | MP0004883_abnormal_blood_vessel | 0.45262520 |
| 126 | MP0005408_hypopigmentation | 0.45051412 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.44389030 |
| 128 | MP0004381_abnormal_hair_follicle | 0.44388046 |
| 129 | MP0000598_abnormal_liver_morphology | 0.44312060 |
| 130 | MP0004924_abnormal_behavior | 0.44267907 |
| 131 | MP0005386_behavior/neurological_phenoty | 0.44267907 |
| 132 | MP0005023_abnormal_wound_healing | 0.44122556 |
| 133 | MP0008872_abnormal_physiological_respon | 0.44085108 |
| 134 | MP0005389_reproductive_system_phenotype | 0.43835852 |
| 135 | MP0001730_embryonic_growth_arrest | 0.41824288 |
| 136 | MP0002083_premature_death | 0.40667010 |
| 137 | MP0001881_abnormal_mammary_gland | 0.37829367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hemiplegia (HP:0002301) | 8.30361084 |
| 2 | Hypoproteinemia (HP:0003075) | 7.10768816 |
| 3 | Tetraplegia (HP:0002445) | 6.14565226 |
| 4 | Encephalitis (HP:0002383) | 6.12508731 |
| 5 | T lymphocytopenia (HP:0005403) | 5.81615792 |
| 6 | Abnormality of T cell number (HP:0011839) | 5.60371259 |
| 7 | Abnormality of the common coagulation pathway (HP:0010990) | 5.56455885 |
| 8 | Increased serum ferritin (HP:0003281) | 5.44600183 |
| 9 | Aplastic anemia (HP:0001915) | 5.33354492 |
| 10 | Abnormality of macrophages (HP:0004311) | 5.30384809 |
| 11 | Joint swelling (HP:0001386) | 5.14281930 |
| 12 | Increased CSF protein (HP:0002922) | 4.93718551 |
| 13 | Optic neuritis (HP:0100653) | 4.90622704 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 4.90622704 |
| 15 | Nasal polyposis (HP:0100582) | 4.85906969 |
| 16 | Abnormality of iron homeostasis (HP:0011031) | 4.79771054 |
| 17 | Myositis (HP:0100614) | 4.79132085 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.44079660 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 4.44079660 |
| 20 | Hypoalbuminemia (HP:0003073) | 4.39657546 |
| 21 | Abnormal albumin level (HP:0012116) | 4.39657546 |
| 22 | Orchitis (HP:0100796) | 4.24850145 |
| 23 | Increased density of long bones (HP:0006392) | 4.19584319 |
| 24 | Abnormality of transition element cation homeostasis (HP:0011030) | 4.09179236 |
| 25 | Meningitis (HP:0001287) | 3.96121887 |
| 26 | Abnormality of the nasal mucosa (HP:0000433) | 3.91842839 |
| 27 | Abnormal platelet volume (HP:0011876) | 3.70464702 |
| 28 | Abnormality of T cells (HP:0002843) | 3.63831276 |
| 29 | Keratoconjunctivitis sicca (HP:0001097) | 3.58703559 |
| 30 | Hyponatremia (HP:0002902) | 3.57485640 |
| 31 | Stomatitis (HP:0010280) | 3.55323553 |
| 32 | Increased mean platelet volume (HP:0011877) | 3.40351467 |
| 33 | Bilateral sensorineural hearing impairment (HP:0008619) | 3.24064818 |
| 34 | Keratoconjunctivitis (HP:0001096) | 3.19540029 |
| 35 | Hypertriglyceridemia (HP:0002155) | 3.16634798 |
| 36 | 3-Methylglutaconic aciduria (HP:0003535) | 3.10393015 |
| 37 | IgM deficiency (HP:0002850) | 3.08379067 |
| 38 | Abnormality of oral frenula (HP:0000190) | 3.05984482 |
| 39 | Prolonged bleeding time (HP:0003010) | 3.04574508 |
| 40 | Gingival bleeding (HP:0000225) | 3.04089754 |
| 41 | Lymphoma (HP:0002665) | 3.01556010 |
| 42 | Recurrent viral infections (HP:0004429) | 3.00038697 |
| 43 | Abnormality of sodium homeostasis (HP:0010931) | 2.98492098 |
| 44 | Abnormality of intracranial pressure (HP:0012640) | 2.98471828 |
| 45 | Increased intracranial pressure (HP:0002516) | 2.98471828 |
| 46 | Abnormality of binocular vision (HP:0011514) | 2.96360810 |
| 47 | Diplopia (HP:0000651) | 2.96360810 |
| 48 | Thyroiditis (HP:0100646) | 2.96340150 |
| 49 | Arterial thrombosis (HP:0004420) | 2.95552896 |
| 50 | Recurrent bronchitis (HP:0002837) | 2.95126076 |
| 51 | Menorrhagia (HP:0000132) | 2.84025922 |
| 52 | Chronic otitis media (HP:0000389) | 2.80048051 |
| 53 | Petechiae (HP:0000967) | 2.77853090 |
| 54 | Pulmonary embolism (HP:0002204) | 2.77199941 |
| 55 | Hypoplasia of the thymus (HP:0000778) | 2.75181878 |
| 56 | IgA deficiency (HP:0002720) | 2.72063143 |
| 57 | Abnormality of the prostate (HP:0008775) | 2.68418849 |
| 58 | Eczematoid dermatitis (HP:0000976) | 2.66302043 |
| 59 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.66181067 |
| 60 | Oral leukoplakia (HP:0002745) | 2.59626309 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.57446099 |
| 62 | Recurrent skin infections (HP:0001581) | 2.56327854 |
| 63 | Autoimmune thrombocytopenia (HP:0001973) | 2.56284660 |
| 64 | Agammaglobulinemia (HP:0004432) | 2.55505201 |
| 65 | Vasculitis (HP:0002633) | 2.55054124 |
| 66 | Acute necrotizing encephalopathy (HP:0006965) | 2.53954553 |
| 67 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.51573106 |
| 68 | Increased intramyocellular lipid droplets (HP:0012240) | 2.49532087 |
| 69 | Recurrent fungal infections (HP:0002841) | 2.48745474 |
| 70 | Abnormal platelet function (HP:0011869) | 2.47442392 |
| 71 | Impaired platelet aggregation (HP:0003540) | 2.47442392 |
| 72 | Increased hepatocellular lipid droplets (HP:0006565) | 2.46185470 |
| 73 | Hyperbilirubinemia (HP:0002904) | 2.45233968 |
| 74 | Anorexia (HP:0002039) | 2.44873892 |
| 75 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.44638230 |
| 76 | Ureteral obstruction (HP:0006000) | 2.44418889 |
| 77 | Epistaxis (HP:0000421) | 2.42267049 |
| 78 | Pulmonary infiltrates (HP:0002113) | 2.42158088 |
| 79 | Abnormality of eosinophils (HP:0001879) | 2.41753481 |
| 80 | Abnormality of the fingertips (HP:0001211) | 2.40867881 |
| 81 | Acute hepatic failure (HP:0006554) | 2.40072367 |
| 82 | Eosinophilia (HP:0001880) | 2.33775305 |
| 83 | Severe combined immunodeficiency (HP:0004430) | 2.33696882 |
| 84 | Purpura (HP:0000979) | 2.32738232 |
| 85 | Mitochondrial inheritance (HP:0001427) | 2.32177592 |
| 86 | Recurrent abscess formation (HP:0002722) | 2.28393015 |
| 87 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.26033858 |
| 88 | Lipid accumulation in hepatocytes (HP:0006561) | 2.20496240 |
| 89 | Leukocytosis (HP:0001974) | 2.19700340 |
| 90 | Acute encephalopathy (HP:0006846) | 2.18685031 |
| 91 | Carpal bone hypoplasia (HP:0001498) | 2.18510434 |
| 92 | Gangrene (HP:0100758) | 2.17574236 |
| 93 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.17083245 |
| 94 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.17083245 |
| 95 | Pancytopenia (HP:0001876) | 2.16949817 |
| 96 | Molar tooth sign on MRI (HP:0002419) | 2.13285356 |
| 97 | Abnormality of midbrain morphology (HP:0002418) | 2.13285356 |
| 98 | Trigonocephaly (HP:0000243) | 2.12991076 |
| 99 | Renal cortical cysts (HP:0000803) | 2.11855375 |
| 100 | Combined immunodeficiency (HP:0005387) | 2.10723045 |
| 101 | Renal Fanconi syndrome (HP:0001994) | 2.08556440 |
| 102 | Abnormality of the renal cortex (HP:0011035) | 2.07707776 |
| 103 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.07058909 |
| 104 | Leukopenia (HP:0001882) | 2.05324036 |
| 105 | Hemoptysis (HP:0002105) | 2.04227498 |
| 106 | Inflammation of the large intestine (HP:0002037) | 2.04152213 |
| 107 | Increased muscle lipid content (HP:0009058) | 2.03424033 |
| 108 | Periodontitis (HP:0000704) | 2.03176328 |
| 109 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.02807584 |
| 110 | Gastrointestinal inflammation (HP:0004386) | 2.01916260 |
| 111 | Gastrointestinal infarctions (HP:0005244) | 2.01567350 |
| 112 | Progressive macrocephaly (HP:0004481) | 2.00843013 |
| 113 | Bronchitis (HP:0012387) | 1.97922948 |
| 114 | Increased CSF lactate (HP:0002490) | 1.97887411 |
| 115 | Duplicated collecting system (HP:0000081) | 1.97831613 |
| 116 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.95469488 |
| 117 | Abnormality of T cell physiology (HP:0011840) | 1.94729878 |
| 118 | Chest pain (HP:0100749) | 1.93641378 |
| 119 | Mediastinal lymphadenopathy (HP:0100721) | 1.93115856 |
| 120 | Arthralgia (HP:0002829) | 1.92717856 |
| 121 | Thrombocytosis (HP:0001894) | 1.90219233 |
| 122 | Pulmonary fibrosis (HP:0002206) | 1.89486581 |
| 123 | IgG deficiency (HP:0004315) | 1.87227099 |
| 124 | Increased IgM level (HP:0003496) | 1.87225677 |
| 125 | Chronic obstructive pulmonary disease (HP:0006510) | 1.86854169 |
| 126 | Obstructive lung disease (HP:0006536) | 1.86854169 |
| 127 | Anhidrosis (HP:0000970) | 1.85715502 |
| 128 | Granulocytopenia (HP:0001913) | 1.85351041 |
| 129 | Abnormality of the renal collecting system (HP:0004742) | 1.85016552 |
| 130 | Cerebral edema (HP:0002181) | 1.83243477 |
| 131 | Skin rash (HP:0000988) | 1.79869908 |
| 132 | Panhypogammaglobulinemia (HP:0003139) | 1.78064617 |
| 133 | Deviation of the thumb (HP:0009603) | 1.77662322 |
| 134 | Increased IgE level (HP:0003212) | 1.74566404 |
| 135 | Hypobetalipoproteinemia (HP:0003563) | 1.73872669 |
| 136 | Ureteral stenosis (HP:0000071) | 1.72810612 |
| 137 | Keratitis (HP:0000491) | 1.71575385 |
| 138 | Papilledema (HP:0001085) | 1.70354767 |
| 139 | Abnormality of the metopic suture (HP:0005556) | 1.70127958 |
| 140 | Lymphopenia (HP:0001888) | 1.68795504 |
| 141 | Chronic diarrhea (HP:0002028) | 1.68346173 |
| 142 | Autoimmune hemolytic anemia (HP:0001890) | 1.64983181 |
| 143 | Pustule (HP:0200039) | 1.64935653 |
| 144 | Abnormality of the pleura (HP:0002103) | 1.64873585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 8.23896300 |
| 2 | GRK7 | 5.38926959 |
| 3 | JAK1 | 3.81668799 |
| 4 | MAP4K1 | 3.74491020 |
| 5 | RIPK1 | 3.33095488 |
| 6 | ADRBK2 | 3.10474057 |
| 7 | BCKDK | 3.02571655 |
| 8 | ITK | 2.69370749 |
| 9 | PIK3CA | 2.61040769 |
| 10 | STK10 | 2.58742960 |
| 11 | MAPKAPK3 | 2.48311985 |
| 12 | ZAP70 | 2.12560384 |
| 13 | TAOK2 | 1.93675138 |
| 14 | WNK4 | 1.87489699 |
| 15 | MST4 | 1.85097718 |
| 16 | MAP3K14 | 1.72835105 |
| 17 | PIK3CG | 1.71756411 |
| 18 | JAK3 | 1.68915519 |
| 19 | FES | 1.68268987 |
| 20 | NUAK1 | 1.63864107 |
| 21 | TSSK6 | 1.58160090 |
| 22 | LCK | 1.57248544 |
| 23 | PIM1 | 1.56299729 |
| 24 | TESK2 | 1.55726414 |
| 25 | MATK | 1.55390837 |
| 26 | TRIB3 | 1.51962220 |
| 27 | MAP3K3 | 1.51713136 |
| 28 | NTRK1 | 1.50544150 |
| 29 | TESK1 | 1.47792261 |
| 30 | CSK | 1.43095380 |
| 31 | TYK2 | 1.40393757 |
| 32 | EPHB1 | 1.38101763 |
| 33 | KIT | 1.37342888 |
| 34 | ALK | 1.34255660 |
| 35 | IKBKB | 1.28851708 |
| 36 | BUB1 | 1.28397606 |
| 37 | EIF2AK1 | 1.23301189 |
| 38 | CDC7 | 1.21460660 |
| 39 | NLK | 1.20679287 |
| 40 | MAP3K10 | 1.20190647 |
| 41 | EEF2K | 1.17023243 |
| 42 | SRPK1 | 1.15877069 |
| 43 | CDK4 | 1.15480798 |
| 44 | PRKCQ | 1.14009596 |
| 45 | LRRK2 | 1.13591081 |
| 46 | MAP2K3 | 1.13285850 |
| 47 | GRK6 | 1.12137547 |
| 48 | NME1 | 1.10730504 |
| 49 | SYK | 1.06136434 |
| 50 | PRKCH | 0.98377069 |
| 51 | TAOK3 | 0.98329556 |
| 52 | FGFR4 | 0.95295723 |
| 53 | MAP3K12 | 0.94404089 |
| 54 | TLK1 | 0.94125396 |
| 55 | DAPK1 | 0.90133968 |
| 56 | TTN | 0.88069923 |
| 57 | KDR | 0.87135892 |
| 58 | CDK12 | 0.87022357 |
| 59 | BTK | 0.85512965 |
| 60 | JAK2 | 0.83441093 |
| 61 | EIF2AK3 | 0.83190023 |
| 62 | HCK | 0.81606543 |
| 63 | STK39 | 0.80115199 |
| 64 | TBK1 | 0.78094107 |
| 65 | CAMKK2 | 0.77557923 |
| 66 | DMPK | 0.75153753 |
| 67 | SIK2 | 0.74768805 |
| 68 | FGFR3 | 0.73437826 |
| 69 | MAP3K7 | 0.71877263 |
| 70 | LYN | 0.71072981 |
| 71 | ZAK | 0.70262535 |
| 72 | VRK2 | 0.68883189 |
| 73 | BMPR2 | 0.68560270 |
| 74 | IGF1R | 0.66849007 |
| 75 | BLK | 0.63623490 |
| 76 | CDK6 | 0.62702285 |
| 77 | BMX | 0.58727095 |
| 78 | STK16 | 0.57642203 |
| 79 | MAP3K5 | 0.57504884 |
| 80 | EPHA3 | 0.57312343 |
| 81 | CLK1 | 0.54210782 |
| 82 | IRAK3 | 0.53640479 |
| 83 | INSR | 0.52148454 |
| 84 | TNK2 | 0.52065504 |
| 85 | MAP3K1 | 0.51241284 |
| 86 | MARK3 | 0.50926144 |
| 87 | MAP4K2 | 0.49019338 |
| 88 | TEC | 0.47426542 |
| 89 | FGFR1 | 0.45127047 |
| 90 | CHUK | 0.44201381 |
| 91 | MAP3K8 | 0.44149724 |
| 92 | CSNK1A1L | 0.42784231 |
| 93 | WNK1 | 0.41136349 |
| 94 | GRK1 | 0.40419108 |
| 95 | ATR | 0.39682824 |
| 96 | VRK1 | 0.38719897 |
| 97 | IRAK1 | 0.37749782 |
| 98 | PINK1 | 0.37442887 |
| 99 | IKBKE | 0.37255651 |
| 100 | IRAK4 | 0.36371141 |
| 101 | EIF2AK2 | 0.36154999 |
| 102 | FYN | 0.35458029 |
| 103 | CSNK1G2 | 0.34253323 |
| 104 | STK24 | 0.33314549 |
| 105 | CAMK2A | 0.32971979 |
| 106 | PTK6 | 0.32694449 |
| 107 | RPS6KA5 | 0.32434964 |
| 108 | CSF1R | 0.32269645 |
| 109 | NEK1 | 0.31024843 |
| 110 | PDK1 | 0.30662865 |
| 111 | TGFBR2 | 0.30596804 |
| 112 | GSK3A | 0.30562041 |
| 113 | CSNK1G3 | 0.30255496 |
| 114 | ACVR1B | 0.29728204 |
| 115 | CAMK2D | 0.29323645 |
| 116 | NEK2 | 0.29316098 |
| 117 | DAPK2 | 0.29110036 |
| 118 | TRPM7 | 0.28782033 |
| 119 | RPS6KA1 | 0.27953010 |
| 120 | PKN2 | 0.27911248 |
| 121 | MAP2K7 | 0.27741049 |
| 122 | TYRO3 | 0.27620654 |
| 123 | PLK3 | 0.27193757 |
| 124 | TIE1 | 0.27130671 |
| 125 | PIM2 | 0.25294644 |
| 126 | PTK2 | 0.25153162 |
| 127 | MAPKAPK2 | 0.25061116 |
| 128 | PRKCA | 0.24527557 |
| 129 | MYLK | 0.24389615 |
| 130 | TAOK1 | 0.24047598 |
| 131 | SCYL2 | 0.23899104 |
| 132 | OXSR1 | 0.23846119 |
| 133 | CCNB1 | 0.23214537 |
| 134 | PDGFRB | 0.22803910 |
| 135 | GRK5 | 0.22661656 |
| 136 | RAF1 | 0.21711258 |
| 137 | MAP2K6 | 0.21361389 |
| 138 | MAP3K11 | 0.20977705 |
| 139 | PLK4 | 0.20579574 |
| 140 | RPS6KB1 | 0.20522621 |
| 141 | MAPK4 | 0.20480946 |
| 142 | HIPK2 | 0.19890468 |
| 143 | SRC | 0.19658277 |
| 144 | PRKCB | 0.17606482 |
| 145 | PRKG2 | 0.17108524 |
| 146 | RPS6KA4 | 0.16683187 |
| 147 | CHEK1 | 0.16363985 |
| 148 | CSNK1A1 | 0.14670906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 7.95421874 |
| 2 | * Allograft rejection_Homo sapiens_hsa05330 | 5.82932630 |
| 3 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 4.52492941 |
| 4 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 4.01731289 |
| 5 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.82964788 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.29101477 |
| 7 | Viral myocarditis_Homo sapiens_hsa05416 | 3.04237924 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.97553274 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.23809104 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.93128032 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.92365959 |
| 12 | Protein export_Homo sapiens_hsa03060 | 1.84091923 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 1.79468541 |
| 14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.72545253 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60623772 |
| 16 | Asthma_Homo sapiens_hsa05310 | 1.46524617 |
| 17 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.42352181 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.34877226 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33247134 |
| 20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.32802168 |
| 21 | * Apoptosis_Homo sapiens_hsa04210 | 1.31867409 |
| 22 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.31461963 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.29925991 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.19563488 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.19055354 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.15491049 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14704331 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.13430430 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.10236121 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08704522 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08535045 |
| 32 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.08304596 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06798915 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99876741 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96673569 |
| 36 | DNA replication_Homo sapiens_hsa03030 | 0.93970149 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86355666 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84162659 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.82780310 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80270328 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79810528 |
| 42 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.79043504 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78956813 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 0.75401195 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 0.74896377 |
| 46 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74389172 |
| 47 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74174197 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71254082 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.70316739 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69618963 |
| 51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.67900169 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67691168 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.67065960 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65301960 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.65054300 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64648121 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64284072 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63175531 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63009059 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60858155 |
| 61 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60690879 |
| 62 | Mismatch repair_Homo sapiens_hsa03430 | 0.60227886 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59254867 |
| 64 | Proteasome_Homo sapiens_hsa03050 | 0.57162718 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.56975133 |
| 66 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.54944448 |
| 67 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54783071 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.54655154 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53283111 |
| 70 | Phototransduction_Homo sapiens_hsa04744 | 0.53170078 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.51963213 |
| 72 | Influenza A_Homo sapiens_hsa05164 | 0.51886733 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50988311 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50224063 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.48077188 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 0.47604700 |
| 77 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45006553 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44993511 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43639934 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43221386 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42152889 |
| 82 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.41214617 |
| 83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41181405 |
| 84 | Purine metabolism_Homo sapiens_hsa00230 | 0.38363580 |
| 85 | Huntingtons disease_Homo sapiens_hsa05016 | 0.37942955 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37832895 |
| 87 | Prion diseases_Homo sapiens_hsa05020 | 0.35005609 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34979146 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.34785721 |
| 90 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34577279 |
| 91 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.32162644 |
| 92 | RNA degradation_Homo sapiens_hsa03018 | 0.29312597 |
| 93 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.29129774 |
| 94 | RNA transport_Homo sapiens_hsa03013 | 0.29107190 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28699137 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28128830 |
| 97 | Spliceosome_Homo sapiens_hsa03040 | 0.28035479 |
| 98 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.27986564 |
| 99 | Peroxisome_Homo sapiens_hsa04146 | 0.27810063 |
| 100 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.27688695 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | 0.27453530 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27249154 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26166019 |
| 104 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.25519516 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25405271 |
| 106 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.24391107 |
| 107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.24095494 |
| 108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.23978284 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.22919130 |
| 110 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21478863 |
| 111 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20995202 |
| 112 | Base excision repair_Homo sapiens_hsa03410 | 0.19956379 |
| 113 | Basal transcription factors_Homo sapiens_hsa03022 | 0.19253722 |
| 114 | Homologous recombination_Homo sapiens_hsa03440 | 0.18032356 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17926230 |
| 116 | Focal adhesion_Homo sapiens_hsa04510 | 0.17318331 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.15735563 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14057312 |
| 119 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.12933453 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.12627694 |
| 121 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.12101106 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.11855298 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.11119074 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.11047063 |
| 125 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.10439849 |
| 126 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.10373745 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.09883522 |
| 128 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.08705026 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.08598172 |
| 130 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.07898960 |
| 131 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.07679657 |
| 132 | Lysine degradation_Homo sapiens_hsa00310 | 0.06833643 |
| 133 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.06229238 |
| 134 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.06116421 |
| 135 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.05874009 |
| 136 | Cell cycle_Homo sapiens_hsa04110 | 0.05674723 |
| 137 | Long-term potentiation_Homo sapiens_hsa04720 | 0.03733785 |
| 138 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.02065845 |

